Confluent (NASDAQ:CFLT) Downgraded to “Market Perform” Rating by Citizens Jmp

Citizens Jmp lowered shares of Confluent (NASDAQ:CFLTFree Report) from an outperform rating to a market perform rating in a research note published on Friday morning, Marketbeat.com reports.

CFLT has been the topic of a number of other research reports. Robert W. Baird increased their price objective on Confluent from $26.00 to $31.00 and gave the company a “neutral” rating in a report on Tuesday, December 9th. Raymond James Financial downgraded Confluent from an “outperform” rating to a “market perform” rating in a report on Tuesday, December 9th. Oppenheimer cut shares of Confluent from an “outperform” rating to a “market perform” rating in a research note on Tuesday, December 9th. Morgan Stanley raised their target price on shares of Confluent from $25.00 to $27.00 and gave the company an “equal weight” rating in a research note on Tuesday, October 28th. Finally, William Blair lowered shares of Confluent from an “outperform” rating to a “market perform” rating in a research report on Monday, December 8th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, twenty-eight have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $28.71.

Get Our Latest Analysis on CFLT

Confluent Stock Performance

Shares of CFLT opened at $30.36 on Friday. The firm has a market cap of $10.62 billion, a price-to-earnings ratio of -33.73 and a beta of 0.95. The company’s fifty day moving average is $26.38 and its 200-day moving average is $23.20. The company has a quick ratio of 4.01, a current ratio of 4.01 and a debt-to-equity ratio of 0.98. Confluent has a 12 month low of $15.64 and a 12 month high of $37.90.

Confluent (NASDAQ:CFLTGet Free Report) last released its quarterly earnings data on Monday, October 27th. The company reported $0.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.10 by $0.03. Confluent had a negative net margin of 27.32% and a negative return on equity of 25.40%. The business had revenue of $298.52 million during the quarter, compared to analyst estimates of $292.69 million. During the same quarter in the previous year, the business earned $0.10 EPS. Confluent’s quarterly revenue was up 19.3% compared to the same quarter last year. Confluent has set its Q4 2025 guidance at 0.090-0.100 EPS and its FY 2025 guidance at 0.390-0.400 EPS. Equities analysts expect that Confluent will post -0.83 EPS for the current fiscal year.

Insider Buying and Selling at Confluent

In related news, CRO Ban Ryan Norris Mac sold 3,053 shares of the business’s stock in a transaction dated Tuesday, December 23rd. The stock was sold at an average price of $29.96, for a total transaction of $91,467.88. Following the transaction, the executive directly owned 332,679 shares in the company, valued at $9,967,062.84. The trade was a 0.91% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Lara Caimi sold 1,074 shares of Confluent stock in a transaction that occurred on Wednesday, December 10th. The stock was sold at an average price of $30.00, for a total value of $32,220.00. Following the sale, the director directly owned 11,524 shares in the company, valued at $345,720. The trade was a 8.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 1,455,620 shares of company stock valued at $40,630,407 over the last quarter. Company insiders own 9.20% of the company’s stock.

Hedge Funds Weigh In On Confluent

A number of hedge funds have recently made changes to their positions in CFLT. Vanguard Group Inc. lifted its stake in Confluent by 10.5% during the third quarter. Vanguard Group Inc. now owns 31,347,214 shares of the company’s stock worth $620,675,000 after purchasing an additional 2,970,708 shares during the period. Champlain Investment Partners LLC boosted its stake in Confluent by 6.7% in the 2nd quarter. Champlain Investment Partners LLC now owns 11,590,026 shares of the company’s stock valued at $288,939,000 after buying an additional 727,943 shares in the last quarter. William Blair Investment Management LLC grew its position in Confluent by 3.8% in the second quarter. William Blair Investment Management LLC now owns 9,639,102 shares of the company’s stock valued at $240,303,000 after acquiring an additional 356,277 shares during the period. Franklin Resources Inc. raised its stake in Confluent by 1.7% during the second quarter. Franklin Resources Inc. now owns 8,592,443 shares of the company’s stock worth $214,210,000 after acquiring an additional 143,232 shares in the last quarter. Finally, Jericho Capital Asset Management L.P. acquired a new position in Confluent during the third quarter worth $163,667,000. Institutional investors and hedge funds own 78.09% of the company’s stock.

About Confluent

(Get Free Report)

Confluent, Inc (NASDAQ: CFLT) is a leading provider of an event streaming platform built on Apache Kafka. The company’s flagship offerings include Confluent Platform—a self-managed software solution—and Confluent Cloud, a fully managed service designed to simplify real-time data processing across hybrid and multi-cloud environments. These products enable enterprises to collect, process and distribute high volumes of data in real time, supporting use cases such as fraud detection, supply chain optimization and personalized customer experiences.

Founded in 2014 by Apache Kafka co-creators Jay Kreps, Neha Narkhede and Jun Rao, Confluent has driven the commercialization of Kafka technologies and extended the platform with tools for data integration, stream processing and enterprise-grade security.

Featured Articles

Analyst Recommendations for Confluent (NASDAQ:CFLT)

Receive News & Ratings for Confluent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Confluent and related companies with MarketBeat.com's FREE daily email newsletter.